These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37450837)
1. Dopamine-Conjugated Bovine Serum Albumin Nanoparticles Containing pH-Responsive Catechol-V(III) Coordination for In Vitro and In Vivo Drug Delivery. Argitekin E; Ersoz-Gulseven E; Cakan-Akdogan G; Akdogan Y Biomacromolecules; 2023 Aug; 24(8):3603-3618. PubMed ID: 37450837 [TBL] [Abstract][Full Text] [Related]
2. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
3. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release. Yang Z; Zhang N; Ma T; Liu L; Zhao L; Xie H Drug Deliv; 2020 Dec; 27(1):1156-1164. PubMed ID: 32755291 [TBL] [Abstract][Full Text] [Related]
4. Folate-receptor mediated pH/reduction-responsive biomimetic nanoparticles for dually activated multi-stage anticancer drug delivery. Wang D; Chen W; Li H; Huang G; Zhou Y; Wang Y; Wan W; You B; Liu Y; Zhang X Int J Pharm; 2020 Jul; 585():119456. PubMed ID: 32492507 [TBL] [Abstract][Full Text] [Related]
5. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery. Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261 [TBL] [Abstract][Full Text] [Related]
6. EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. Ye Z; Zhang Y; Liu Y; Liu Y; Tu J; Shen Y Int J Nanomedicine; 2021; 16():2443-2459. PubMed ID: 33814909 [TBL] [Abstract][Full Text] [Related]
7. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line. Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815 [No Abstract] [Full Text] [Related]
8. Ultrasound-degradable serum albumin nanoplatform for in situ controlled drug release. Du J; Zhang Y; Ge H; Shi C; Long S; Sun W; Fan J; Peng X Chem Commun (Camb); 2020 Jul; 56(54):7503-7506. PubMed ID: 32501465 [TBL] [Abstract][Full Text] [Related]
9. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Palanikumar L; Al-Hosani S; Kalmouni M; Nguyen VP; Ali L; Pasricha R; Barrera FN; Magzoub M Commun Biol; 2020 Mar; 3(1):95. PubMed ID: 32127636 [TBL] [Abstract][Full Text] [Related]
10. Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells. Haque ST; Islam RA; Gan SH; Chowdhury EH Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937817 [No Abstract] [Full Text] [Related]
11. Conjugated Polymer Nanoparticles Based on Copper Coordination for Real-Time Monitoring of pH-Responsive Drug Delivery. Li J; Du N; Tan Y; Hsu HY; Tan C; Jiang Y ACS Appl Bio Mater; 2021 Mar; 4(3):2583-2590. PubMed ID: 35014375 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system. Gharbavi M; Johari B; Eslami SS; Mousazadeh N; Sharafi A Cell Biol Int; 2020 Dec; 44(12):2485-2498. PubMed ID: 32841441 [TBL] [Abstract][Full Text] [Related]
13. Albumin-bioinspired iridium oxide nanoplatform with high photothermal conversion efficiency for synergistic chemo-photothermal of osteosarcoma. Gu W; Zhang T; Gao J; Wang Y; Li D; Zhao Z; Jiang B; Dong Z; Liu H Drug Deliv; 2019 Dec; 26(1):918-927. PubMed ID: 31526064 [TBL] [Abstract][Full Text] [Related]
14. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery. Bae Y; Kim Y; Lee ES Molecules; 2021 Jun; 26(12):. PubMed ID: 34200716 [TBL] [Abstract][Full Text] [Related]
15. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo. Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887 [TBL] [Abstract][Full Text] [Related]
16. Coordination bonding based pH-responsive albumin nanoparticles for anticancer drug delivery. Li C; Xing L; Che S Dalton Trans; 2012 Apr; 41(13):3714-9. PubMed ID: 22370556 [TBL] [Abstract][Full Text] [Related]
17. BSA-based Cu Liu Z; Chan L; Ye X; Bai Y; Chen T Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097 [TBL] [Abstract][Full Text] [Related]
18. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery. Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058 [TBL] [Abstract][Full Text] [Related]
19. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs. Montero N; Pérez E; Benito M; Teijón C; Teijón JM; Olmo R; Blanco MD Int J Pharm; 2019 Jan; 554():337-351. PubMed ID: 30439492 [TBL] [Abstract][Full Text] [Related]